The state of Oklahoma has received $1.37 million as part of a settlement with Bristol-Myers Squibb in a case in which it allegedly overcharged state and federal medical programs.
Oklahoma’s share was part of a $389 million settlement that the drug company paid to 43 states, the District of Columbia and federal government, said Charlie Price, spokesman for the Oklahoma Attorney General’s office.
“The issue was that they had inflated prices for drugs that were purchased by the state and federal Medicaid programs,” Price said. “We got the check two or three weeks ago.”
Most of the settlement money went to the Oklahoma Health Care Authority to reimburse it for the overcharges, Price said. The Attorney General’s office received a share that represented the civil penalties that Bristol-Meyers Squibb paid.
The largest share of the overall settlement, about 70 percent, went to the federal government, Price said.